Prodrug — CYP2D6 O-demethylates to hydromorphone, which is the more potent active metabolite. CYP2D6 poor metabolisers get reduced analgesia. µ-opioid receptor agonist (same family as morphine). Most commonly co-formulated with acetaminophen, whose 4 g/day ceiling sets the hard dose cap.
Half-Life & Elimination Curve (PO: 4h)
Plasma (PO)t½ Decay (4h)Effect Site (ke0)
0×t½0h100%(10 µg/L)
1×t½4h50%(5.02 µg/L)
2×t½8h25%(2.51 µg/L)
3×t½12h12.5%(1.26 µg/L)
4×t½16h6.3%(0.628 µg/L)
5×t½20h3.1%(0.314 µg/L)
Elimination t½4h (PO)
Rate Constant (ke)0.173 h⁻¹
Time to Peak (Tmax)2.12h
Est. Peak (Cmax)10 µg/L
Clearance (CL)39.9 L/h
97% Washout (5×t½)20h
Dosing Guidelines
Oral (PO): Typical 6.67 mg (Range: 5–10 mg)
Pharmacokinetic Parameters
Oral (PO): Bioavailability (F): 50% · Volume of Distribution (Vd): 230 L · Absorption (ka): 1 h⁻¹ (t½ka ≈ 42m) [PMID 25542074]